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Background: Headache disorders are under-recognized and under-diagnosed. A principal factor in their suboptimal
management is lack of headache-related training among health-care providers, especially in primary care. In Estonia,
general practitioners (GPs) refer many headache patients to neurological specialist services, mostly unnecessarily. GPs
request “diagnostic” investigations, which are usually unhelpful and therefore wasteful. GP-made headache diagnoses
are often arcane and non-specific, and treatments based on these are inappropriate.
The aim of this study was to develop, implement and test an educational model intended to improve headache-related
primary health care in Estonia.
Methods: This was a controlled study consisting of baseline observation, intervention and follow-up observation using
the same measures of effect. It involved six GPs in Põlva and the surrounding region in Southern Estonia, together with
their future patients presenting consecutively with headache as their main complaint, all with their consent. The primary
outcome measure was referral rate (RR) to neurological specialist services. Secondary measures included number
of GP-requested investigations, GP-made headache diagnoses and how these conformed to standard terminology
(ICD-10), and GP-recommended or initiated treatments.
Results: RR at baseline (n = 490) was 39.5 %, falling to 34.7 % in the post-intervention group (n = 295) (overall reduction
4.8 %; p = 0.21). In the large subgroup of patients (88 %) for whom GPs made clearly headache-related ICD-10 diagnoses,
RR fell by one fifth (from 40 to 32 %; p = 0.08), but the only diagnosis-related RR that showed a statistically significant
reduction was (pericranial) myalgia (19 to 3 %; p = 0.03). There was a significant increase towards use of more specific
diagnoses. Use of investigations in diagnosing headache reduced from 26 to 4 % (p < 0.0001). Initiation of treatment by
GPs increased from 58 to 81 % (p < 0.0001).
Conclusions: These were modest changes in GPs’ entrenched behaviour. Nevertheless they were empirical evidence that
GPs’ practice in the field of headache could be improved by structured education. Furthermore, the changes were likely
to be cost-saving. To our knowledge this study is the first to produce such evidence.
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Table 1 Headache services organised on three levels [7]
Level 1. General
primary care
• Frontline headache services (accessible first
contact for most people with headache)
• Ambulatory care delivered by primary
health-care providers




• Ambulatory care delivered by physicians
with a special interest in headache
• Referring when necessary to:
Level 3. Headache
specialist centres
• Advanced multidisciplinary care delivered
by headache specialists in hospital-based
centres
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Throughout Europe, and worldwide, headache disorders
are highly prevalent and commonly disabling, causing heavy
personal burdens and very substantial socioeconomic cost
[1]. In the European Union (EU), headache disorders cost
national economies well in excess of €100 billion annually
[2]. Globally, headache disorders are the third cause of
disability [3, 4]. Despite these compelling statistics, head-
ache disorders are under-recognized, under-diagnosed and
undertreated everywhere [1]. A principal factor in subopti-
mal treatment is lack of knowledge amongst health-care
providers of the nature and good management of headache
disorders, and this is especially so in primary care where
most headache should be managed [1]. This is itself the
result of very limited and wholly inadequate commitment
to these disorders in medical undergraduate curricula and
continuing medical education [1].
One consequence is poor outcomes. These lead in
turn to patient dissatisfaction, diminished expectation,
low consultation rates and persistence of these burdens
largely unmitigated. Other consequences are unneces-
sary investigations and referrals to specialist care [1],
which are wasteful of scarce health-care resources.
This spectrum of problems is encountered in Estonia,
a small country of approximately 1.3 million people.
Here, as elsewhere, there is a clear need for improving
headache-related primary health care. Estonia is a mem-
ber of the EU, but the legacy of the former Soviet health
system is entrenched: purposeless over-investigation, ap-
plication of arcane diagnoses, with prescription of in-
appropriate (often vasoactive) treatments based upon
these, and very high dependence on specialist referral
[5]. These behaviours are not likely easily to be changed,
but the best means of doing so, with expectation of im-
provement in care, lies in education of health-care pro-
viders, especially in primary care [1, 6].
The aim of this study, undertaken as a project within
the Global Campaign against Headache, was to develop,
implement and test an educational model intended to
improve headache care delivered by general practitioners
(GPs) in Estonia. The primary hypothesis was that a
well-structured but limited (as opposed to intensive)
programme of education of GPs in headache disorders
and their management would reduce referrals. We se-
lected referral rate (RR) to specialist care as the principal
outcome measure because such referrals are easily and
objectively measurable. Whilst we could not, on an indi-
vidual level, determine whether or not a particular refer-
ral was appropriate, we could take an informed view on
whether overall RR was excessive and therefore wasteful
[7]. A secondary hypothesis was that education would
lessen the plethora of investigations performed by GPs
in headache patients; as an outcome measure, investiga-
tion rate had the same characteristics as RR.Methods
Ethics
This study was approved by the Ethics Review Committee
on Human Research of the University of Tartu. Informed
consent was obtained from all participants: GPs and their
patients. Data-protection legislation was complied with.Study design
This was a controlled study, which consisted of baseline
observation, intervention and outcome observation using
the same measures.Setting and subjects
The project was conducted in the town of Põlva and
the surrounding region in Southern Estonia, with a
population of about 30,500. Approximately 12,500 in-
habitants were registered at the only outpatients’ clinic
in Põlva, where seven GPs were working. GPs seeking
specialist care referred their headache patients first to
the single neurologist at Põlva Hospital (level two in
the European model of organization of headache ser-
vices [7] described by Lifting The Burden [LTB] and the
European Headache Federation [EHF]) (summarised in
Table 1). In case of need, GPs directly and the local
neurologist might both send patients further, to Tartu
University Hospital, for higher-level neurological con-
sultation (level three [7]).
The intervention involved the GPs and their future pa-
tients presenting consecutively with headache as their
main complaint. The GPs were the research subjects.
Their future patients were not subjects directly, but were
beneficiaries of the intervention, who provided data for
some of the outcome measures. Additionally, the records
of consecutive similar past patients (who were not ex-
cluded from becoming future patients) were scrutinised
to establish baseline performance of GPs.
Age, gender and educational level of each patient were
registered.
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The objective of the intervention was to provide GPs
with sufficient understanding to manage, competently
but not expertly, those headache disorders that are com-
mon in primary care. The intervention consisted of:
a) two educational one-day (6-h) courses to all
participating GPs:
day one: didactic lectures by headache-specialists,
based on the European principles of diagnosis and
management of common headache disorders [8],
including the recognition of important secondary
headaches, and other materials in Aids for manage-
ment of common headache disorders in primary care
published jointly by LTB and EHF [9];
day two (four weeks after day one): clarifying and
reinforcing discussions between the GPs and
headache specialists, including analysis of clinical
cases presented by the specialists and GPs from
their own practices;
b) educational materials and management aids for GPs
[9] translated into Estonian and (in the case only of
information leaflets on headache disorders for
patients) also into Russian.
Outcome measures
Outcome measures were collected from the two groups:
baseline data were collected retrospectively from past
patients for the period prior to study commencement
and post-intervention data were gathered prospectively
from patients consulting after the intervention.
The primary outcome measure was RR: the percentage
of patients referred to levels two or three. The primary
analysis was the change in RR post-intervention.
Secondary outcome measures included GP-requested
investigations (laboratory tests and xrays, but not CT [this
and MRI are not ordered by GPs in Estonia]), GP-made
headache diagnoses and GP-recommended and/or initi-
ated treatments. Patients’ comorbidities were recorded.
All these data were acquired from the electronic
medical records.
In addition, past patients as well as those included
prospectively were contacted during the course of the
study by telephone; those who consented participated in
the following enquiries in their native language (Estonian
or Russian):
a) satisfaction with care, rated on a numerical rating
scale (NRS) of 0–10 where 0 = “very dissatisfied” and
10 = “very satisfied”;
b) adequacy of care, assessed by the Headache Under-
Response to Treatment (HURT) questionnaire [10];
c) burden of headache, assessed by the Headache-
Attributed Lost Time (HALT) questionnaire [11];d) quality of life, assessed by the RAND 36-Item Health
Survey 1.0 questionnaire (RAND-36) [12];
e) health satisfaction (HS) and quality of life satisfaction
(QoLS) assessed by the first two questions of
WHOQoL-8 [13], rated on a NRS of 1–5 where 1 was
least, 3 was neutral and 5 was the highest level of
satisfaction.
Statistics
Power calculation estimated that 273 participants were re-
quired per group assuming that RR would be 25 % at
baseline and fall to 15 % after intervention and using a
one-sided test with 5 % significance level and 90 % power.
Data were collected and analysed using software R, ver-
sion 3.0.3 for Windows. Results were adjusted for age and
gender. Means ± standard deviations (SDs) were used as
descriptive statistics. Pearson’s chi-squared test was used
to compare RRs between baseline and post-intervention
groups, and the same and Fisher’s exact test were used for
other dichotomous variables. The relationships between
NRS, QoLS and HS were tested with Spearman’s correl-
ation coefficient (CC). Student’s t-test was used to evaluate
differences in RAND-36. Results were considered to be
statistically significant when p < 0.05.
Results
Six of the seven GPs consented to participate in the
study. It became evident that our assumption regarding
the baseline RR was incorrect (see below): in order to
achieve adequate statistical power, the baseline group in-
cluded 490 patients seen during two years prior to the
first day of the intervention while the post-intervention
group consisted of 295 consecutive patients consulting
during one year after the second day of the intervention.
There was female predominance in both groups: 73 %
(357/490) in the baseline and 75 % (221/295) in the
post-intervention group (the difference being insignifi-
cant: p = 0.58). The mean age of the baseline group
(43.2 ± 15.8 years) was 3.6 years lower than that of the
post-intervention group (46.8 ± 17.1; p = 0.004). There
was no apparent difference between groups in level of
education (p = 0.48), but over two thirds of patients
chose not to disclose this information.
For the primary outcome, 476/490 baseline records
(data-missing rate 2.9 %) and 294/295 post-intervention
records (data-missing rate 0.3 %) were included. Baseline
RR was 39.5 %; with our patient numbers we had 88 %
power to see a reduction of 10 % (ie, to 29.5 %). How-
ever the overall reduction was only 4.8 % to 34.7 %,
which did not reach significance (p = 0.21). When RR
was analysed for different diagnoses used by the GPs ac-
cording to the International Classification of Diseases
(ICD-10) [14], there were clear trends towards reduction
(Table 2). The most frequently used ICD-10 diagnoses at
Table 2 Referral rates according to ICD-10 diagnoses before
and after intervention
ICD-10 diagnosis Referral rate p
Baseline Post-
intervention
G44.2 Tension-type headache 58/119 (49 %) 50/115 (43 %) 0.50
G43 Migraine 22/48 (46 %) 15/45 (33 %) 0.31
G44 Other headache syndromes
and R51 Headache
79/178 (44 %) 10/38 (26 %) 0.06
M79.1 (Pericranial) myalgia 20/108 (19 %) 1/36 (3 %) 0.03
Total for four headache
diagnostic groups
179/453 (40 %) 76/234 (32 %) 0.08
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dromes), G44.2 (tension-type headache), M79.1 (myalgia
[implying pericranial myalgia]), R51 (headache), G43
(migraine) and G43.9 (unspecified migraine). RR for pa-
tients with a diagnosis of tension-type headache de-
creased from 49 to 43 %, for patients with migraine
from 46 to 33 % and for patients with non-specific head-
ache diagnoses (G44 or R51) from 44 to 26 %. All these
trends remained statistically insignificant, although the
last was close (p = 0.06). The only diagnosis-related RR
that showed a statistically significant reduction was that
for (pericranial) myalgia (19 to 3 %; p = 0.03).
Within the spectrum of headache diagnoses used by
GPs, there was a significant increase towards using those
that were more specific (Table 3, Fig. 1).
Requests for diagnostic investigations for headache re-
duced from 26 % (125/490) at baseline to 4 % (13/295)
post-intervention (p < 0.0001) (Fig. 2). Within these
numbers, laboratory investigations fell from 22 to 1 %
(p < 0.0001) and xrays from 7 to 3 % (p = 0.038). These
changes were noted within all diagnostic groups, being
most clear-cut for migraine, for which there were no in-
vestigations performed at all post-intervention (reduc-
tion from 14 to 0 %; p = 0.01).
Initiation of treatment by GPs increased from 58 %
(286/490) at baseline to 81 % (239/295) post-intervention
(p < 0.0001) (Fig. 2). Furthermore, use of more than one
treatment option increased from 14 % (67/490) to 41 %
(120/295) (p < 0.0001).Table 3 Usage of the most frequent diagnoses before and after inte
ICD-10 diagnosis




G43 Migraine and G43.9 Unspecified migraine
G43.0, G43.1, G43.2 and G43.8 Specified migraine subtypesProportions responding to enquiries into satisfaction
with care were low: 155 patients (31.6 %) at baseline and
87 (29.5 %) post-intervention. Non-responders in the
baseline group were somewhat younger (41.9 ± 15.8
versus 46.1 ± 15.2 years; p = 0.006) and included more
men (31 % versus 19 %; p = 0.04). Overall satisfaction
with care showed very little change in NRS mean score:
from 6.4 ± 2.5 at baseline to 6.7 ± 2.3 post-intervention,
which was not significant (p = 0.36). We found no differ-
ences by diagnostic groups, or in those in whom investi-
gations were performed or treatments initiated, or in
those referred.
There were, similarly, no significant changes in HS
(p = 0.22) or QoLS (p = 0.66). The number of comor-
bidities was strongly correlated with lower scores in
HS in both groups (baseline CC: −0.23; p = 0.004; post-
intervention CC: −0.32; p = 0.002). Proportions respond-
ing to the HALT and HURT questionnaires were also low:
34.9 % in the baseline and 29.8 % in the post-intervention
groups. Again, non-responders at baseline included more
men (32 % versus 19 %; p = 0.003). There was no meaning-
ful change between groups in either HURT or HALT
scores (mean HALT scores were 2.8 (±1.3) at baseline and
2.9 (±1.3) post-intervention; p = 0.49). There were no sig-
nificant overall changes in QoL measured by RAND-36,
or in any of the domains.
Discussion
This controlled intervention study has shown that GPs’
behaviours were changed and practice improved by a
structured educational programme, albeit not in a way
that was reflected in all measures. In particular, the fall
in RR (the primary outcome measure) was statistically
insignificant; on the other hand, GPs made more
disease-specific diagnoses while requesting far fewer in-
vestigations, and they became much more willing to
initiate treatment. It should be noted that, despite the
difference in their sizes, the two groups of patients on
whom these comparisons were based were demograph-
ically similar. Although the age difference (43.2 versus
46.8 years) was significant statistically, it was not so
clinically.
To our knowledge this is the first study to demon-
strate empirically that GPs’ practice in the field ofrvention
Baseline Post-intervention p
134 (27.3 %) 23 (7.8 %) <0.0001
120 (24.5 %) 115 (39.0 %) <0.0001
111 (22.7 %) 36 (12.2 %) 0.0003
55 (11.2 %) 16 (5.4 %) 0.009
46 (9.4 %) 28 (9.5 %) 1
4 (0.8 %) 17 (5.8 %) <0.0001
Fig. 1 Usage of the most frequent diagnoses before and after intervention. G44: other headache syndromes; M79.1: (pericranial) myalgia; R51:
headache; G43: migraine; G43.9: unspecified migraine; G43.x: specified migraine subtype; G44.2: tension-type headache. The figure depicts a clear
trend, post-intervention, away from use of non-specific diagnoses towards more specific diagnoses
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The Dutch study of Smelt et al. [15], aimed specifically
at migraine management and recruiting patients already
on triptan therapy, failed to show a beneficial effect. This
controlled trial employed clinical outcomes, and perhaps
demonstrated the difficulties associated with them. The
Norwegian study of Kristoffersen et al. [16], targeting
medication-overuse headache only, improved outcomes
in an intervention group but the essential element of the
intervention was to equip GPs with a “simple and effective
instrument” as a management aid; the educational elem-
ent was secondary to this. Both these studies had much
narrower focus than ours; we assessed the provision ofFig. 2 Requests for investigations and initiation of treatment before and af
increase in the latter post-interventionheadache care to unselected patients, which was a major
strength in both purpose and study design.
That there was only a small and statistically insignifi-
cant reduction in the primary outcome measure – the
overall RR – was disappointing, especially since baseline
RR was much higher (39 %) than anticipated (25 %).
However, for patients with clearly headache-related GP-
made diagnoses, RR fell by one fifth (from 40 to 32 %;
p = 0.08), suggesting some gain in confidence in man-
aging patients with primary headache without referral
to a neurologist.
Only for patients diagnosed with (pericranial) myalgia
was RR reduced significantly, but this outcome waster intervention. The figure depicts a reduction in the former and an
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use of this diagnosis (M79.1). We did not analyse diag-
nostic changes case-by-case or perform quality analysis
of diagnoses, but can reasonably speculate that, with bet-
ter knowledge applied to recognizing and diagnosing
tension-type headache, inappropriate use of M79.1 gave
way to correct usage of G44.2 for this disorder. In keeping
with this supposition, employment of the latter diagnosis
significantly increased post-intervention. Also there was a
significant reduction in diagnoses that did not specify a
primary headache type. In other words, patients left their
GPs’ offices less frequently with diagnoses of headache as
a symptom and more frequently with diagnoses naming
the disease causing this symptom. GPs’ practice shifted
towards themselves diagnosing the most common primary
headaches.
Key to this is that primary headaches are diagnosed
clinically, rarely with need for investigations. Our results
show that, post-intervention, GPs substantially reduced
their demands for diagnostic investigations, eliminating
them altogether in the case of migraine. Not only was
this further evidence of learning and of confidence
gained as a result, but also it produced immediate cost
savings. Our study was not designed to measure cost-
effectiveness, but this finding may be one of particular
importance because it indicates that health-care re-
sources can be conserved.
In line with an increased rate of specific diagnosis, the
study found a greatly enhanced rate of GP-initiated
treatment. At baseline, 42 % of patients appeared to re-
ceive no treatment recommendations from their GPs;
post-intervention, this fell to 19 % – that is to say, 81 %
of patients left their GPs’ offices with clear treatment op-
tions recommended or prescribed. It was not possible in
the context of the study to make any judgement of the
appropriateness of treatment initiated.
Interestingly, all these changes in GPs’ practice post-
intervention had no discernible influence on patient-
reported outcomes – satisfaction with care, satisfaction
with health and quality of life, lost productive time or
quality-of-life measures. It should be noted here that the
instruments used, while not directly validated in the
study population, had all been employed in multiple
countries, cultures and languages. Where patient satis-
faction is concerned, there are multiple determinants
that might explain failure to indicate benefit. For ex-
ample, we sought to reduce the use of investigations be-
cause these do not contribute usefully to the diagnosis
of headache disorders in primary care. Similarly we
aimed to reduce RR because the proportion of patients
who should be referred – for diagnostic or management
difficulties or for secondary headache – is much smaller
than was the baseline RR [7]. Patients, however, might
not agree that these reductions were in their interest.Also we have to recognise that the study was underpow-
ered at outset for these secondary outcome measures,
added to which the proportions responding to the
patient-directed enquiries were about 30 %. Realistically
we should not attempt to make anything of these, be-
cause, with such low response rates, bias was also likely.
Unfortunately, such response rates are not at all unusual
[2] and, as was the case here, are one of the limitations
of this type of study.
Other limitations here related to the scope of the study.
Its aims did not include quality review of diagnoses, inves-
tigations or treatments; to do any of these would have re-
quired an entirely different approach. Also this study
cannot comment on the duration of found effects, which
was outside the scope of the protocol. In other words we
are not able to answer the question about need for re-
peated interventions over time. Further studies, which are
planned, are required for these purposes.
Finally it must be said that the gains achieved, at least
in the principal outcome measure, were less than had
been hoped for, but the fact that gains were made sug-
gests more would be achieved with more educational in-
put. The cost-effectiveness of this must be investigated,
but is very likely to be favourable given the enormously
high socioeconomic burden of headache [1, 2].Conclusions
GPs’ practice in the field of headache can be improved by
a structured yet limited educational programme. To our
knowledge this study is the first to show this empirically.
Improvements were modest: established practice is
entrenched and change is likely to be slow. But the im-
provements included wider use of headache diagnoses
employing accepted and more specific terminology, less
demand for investigations, which are almost invariably un-
helpful, less dependence on referral, which is often un-
necessary, and greater willingness to initiate treatment.
These changes can be expected to lead to immediate cost
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